Yanagimoto, H., Satoi, S., Yamamoto, T., Yamaki, S., Hirooka, S., Kotsuka, M., . . . Sekimoto, M. (2020). Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma. Cancers (Basel).
Chicago Stili AlıntıYanagimoto, Hiroaki, et al. "Benefits of Conversion Surgery After Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma." Cancers (Basel) 2020.
MLA AlıntıYanagimoto, Hiroaki, et al. "Benefits of Conversion Surgery After Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma." Cancers (Basel) 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..